Development and Validation of a Blood Test Informed Risk Prediction Model for Lung Cancer-The Copenhagen Lung Cancer Risk Model (CPH-Lung).
Adding a blood test to lung cancer risk models improves screening accuracy, especially for women and younger adults.
This PubMed-indexed study examined pURPOSE: Lung cancer screening reduces lung cancer mortality, but identifying high-risk individuals remains difficult. The abstract reports cONCLUSION: After inclusion of blood test information, the CPH-Lung model was more sensitive in the Danish population than PLCOm2012 for prediction of 6-year lung cancer risk particularly among women and younger individuals.
What the study was
- Study design
- Observational/Journal Article
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Why it surfaced
Conservative triage based on the PubMed abstract: observational/journal article with direct watchlist relevance; score reflects metadata and abstract-level evidence only.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.